Press Release NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy 2 hours ago
Press Release NurExone Reports New Preclinical Tissue-Analysis Data Supporting Potential Neuroprotective Effect of ExoPTEN in Acute Spinal Cord Injury Animal Model Aug 14
Press Release NurExone Announces Binding MOU with Made Scientific for U.S. GMP Manufacturing and Commercial Supply Partnership Aug 12
Press Release NurExone Launches Bioprocess Optimization Initiative to Support Commercial and Clinical Readiness Jul 30
Press Release Corporate Updates – NurExone appoints Mr. David Stolick to the Board of Directors Jul 28